[The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents].
Araki
G
G
Public Health Research Center, Morinosato Hospital, Kanagawa, Japan.
D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007269:Injections, Intra-Arterial; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator